HepaRG Cell Test Method Validated for Chemical Safety
Researchers have confirmed the utility of HepaRG cells for assessing how industrial chemicals interact with human liver enzymes.
Updated on Oct. 13, 2026 in Chemistry
Live Poll
Do you trust current laboratory testing methods to accurately identify the safety risks of common chemicals?
A study under the GOLIATH project has validated the use of HepaRG cell lines to monitor the induction of cytochrome P450 enzymes. The method showed high reliability for pharmaceutical substances, though further refinement is needed for non-pharmaceutical chemicals.
Why it matters
Accurate data on how substances affect cytochrome P450 enzymes is critical for chemical safety assessments in the human body. This project aims to expand established drug-testing methodologies into industrial and pesticidal safety sectors.
Laboratories measured activity changes across three key cytochrome P450 enzymes using the HepaRG test method. While performance was consistent for pharmaceuticals, consistency was lower for industrial and pesticidal chemicals.
The players
GOLIATH project
A European Union-funded initiative focused on developing and validating advanced testing methods for chemical safety and endocrine disruptors.
The details
The HepaRG test method utilizes human hepatic cell lines to simulate how the liver processes chemical compounds. Researchers monitor changes in cytochrome P450 — a family of enzymes responsible for the metabolism of drugs and foreign substances — to determine toxicity or metabolic impacts. The GOLIATH project assessed whether this model, typically used for drug pipelines, could serve as a broader regulatory tool for testing industrial chemicals.
Timeline
October 13, 2026: The research findings were published.
The Tech Race
This study follows a pattern set by the GOLIATH project to modernize chemical safety assessment pipelines in the European Union. It specifically seeks to broaden the application of validated liver-cell models to compete with legacy animal-testing benchmarks.
This research provides a more consistent technical framework for chemical safety regulators, potentially improving the reliability of environmental and product toxicity profiles. Practical adoption will depend on future refinements to the method's sensitivity for weak-induction compounds.
The takeaway
The HepaRG method now offers a verified, non-pharmaceutical application for liver enzyme analysis, though consistency for non-drug chemicals remains a hurdle. Watch for follow-up research detailing the specific protocol adjustments intended to capture borderline enzyme induction effects.
Further reading
For broader insights into modernizing molecular analysis, visit our Chemistry section.
Source note: This article includes information reported by Altex.
Live Poll
Do you trust current laboratory testing methods to accurately identify the safety risks of common chemicals?
